<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01388699</url>
  </required_header>
  <id_info>
    <org_study_id>FF_NCRC_Migraine&amp;ED</org_study_id>
    <nct_id>NCT01388699</nct_id>
  </id_info>
  <brief_title>Migraine and Endothelial Dysfunction</brief_title>
  <official_title>Migraine and Endothelial Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, there is evidence that endothelial activation and dysfunction are associated with
      migraine, especially in female migraineurs with aura. Our objectives were to determine
      whether novel endothelial function markers are altered in female migraineurs with aura
      compared to age-matched controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our objectives were to determine whether novel endothelial function methods and novel markers
      of endothelial activation are associated with migraine in female migraineurs with aura.

      Migraine is an independent risk factor for stroke, especially in young women with aura
      symptoms. Endothelial dysfunction is a risk factor for cardiovascular diseases. Recent
      studies suggest that there is a link between migraine with aura and endothelial activation,
      dysfunction and impaired vascular reactivity.

      In this case-control study the investigators examine several novel biomarkers of endothelial
      function such as endothelial progenitor cells and endothelial microparticles as well as novel
      methods such as reactive hyperemic peripheral arterial tonometry in female migraineurs with
      aura and age-matched controls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial Microparticles</measure>
    <time_frame>baseline</time_frame>
    <description>Levels of endothelial microparticlel in the peripheral blood using flow cytometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of circulating Endothelial Progenitor Cells</measure>
    <time_frame>baseline</time_frame>
    <description>Levels of cEPC (CD34+/CD133+/VGF2R/CD31) in % of mononuclear cells using flow cytometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digital pulse volume change</measure>
    <time_frame>baseline</time_frame>
    <description>Digital pulse volume change (with RH PAT as non invasive measurement (PAT-ratio; ENDOPAT, Itamar Medical Ltd.) for non-invasive, peripheral endothelial function</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Migraine With Aura</condition>
  <arm_group>
    <arm_group_label>migraine group</arm_group_label>
    <description>female migraineurs with aura</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>healthy women without headache syndrome</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        female migraineurs from outpatient clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  migraine with aura

          -  age &lt; 50

          -  female gender

        Exclusion Criteria:

          -  severe infectious disease

          -  cardiovascular disease (stroke, coronary heart disease, myocardial infarction)

          -  vasculitis

          -  peripheral artery disease

          -  diabetes mellitus

          -  pregnancy

          -  drug abuse

          -  medication: statin, anticoagulation, aspirin, clopidogrel

          -  intake of triptans &lt;24h
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Liman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Stroke Research Berlin, Charité Campus Mitte</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Stroke Research Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Liman TG, Neeb L, Rosinski J, Wellwood I, Reuter U, Doehner W, Heuschmann PU, Endres M. Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study. Cephalalgia. 2012 Apr;32(6):459-66. doi: 10.1177/0333102412444014. Epub 2012 Apr 20.</citation>
    <PMID>22523187</PMID>
  </reference>
  <reference>
    <citation>Liman TG, Bachelier-Walenta K, Neeb L, Rosinski J, Reuter U, Böhm M, Endres M. Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia. 2015 Feb;35(2):88-94. doi: 10.1177/0333102414529671. Epub 2014 Apr 8.</citation>
    <PMID>24715500</PMID>
  </reference>
  <reference>
    <citation>Liman TG, Neeb L, Rosinski J, Reuter U, Endres M. Stromal Cell-Derived Factor-1 Alpha Is Decreased in Women With Migraine With Aura. Headache. 2016 Sep;56(8):1274-9. doi: 10.1111/head.12839. Epub 2016 May 30.</citation>
    <PMID>27238143</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 5, 2011</study_first_submitted>
  <study_first_submitted_qc>July 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2011</study_first_posted>
  <last_update_submitted>July 16, 2018</last_update_submitted>
  <last_update_submitted_qc>July 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Thomas Liman</investigator_full_name>
    <investigator_title>MD MSC</investigator_title>
  </responsible_party>
  <keyword>Migraine with aura</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Migraine with Aura</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

